喜炎平联合思密达治疗小儿疱疹性咽炎的疗效和安全性评价.docVIP

喜炎平联合思密达（蒙脱石散）治疗小 儿疱疹性咽炎的疗效和安全性评价 鏈金丹 梁河县人民医院 摘要： 目的:评价喜炎平联合思密达（蒙脱石散）治疗小儿疱疹性咽炎的疗效和安全 性。方法:收治小儿疱疹性咽炎患者110例，平分两组。对照组予以口服思密达 治疗，观察组在此基础上予以静脉注射喜炎平治疗，治疗7 d后观察两组患者的 治疗效果。结果:观察组临床疗效明显优于对照组（P〈0.05）。两组未见不良反 应。结论:采用静脉滴注喜炎平注射液联合U服思密达治疗小儿疱疹性咽炎疗效 显著，具有较高的安全性。 关键词： 喜炎平;思密达（蒙脱石散）；疱疹性咽炎; Evaluation on the effect and safety of xiyanping combined with smecta (montmorilIonite powder) in the treatment of children with herpes pharyngitis Beng Youfeng Jiang Chun Hou Junhong Jin Dan The People’s Hospital of Lianghe County; Abstract： Objective:To investigate the effect and safety of xiyanping combined with smecta (montmori 1 lonite powder) in the treatment of children with herpes pharyngitis. Methods: 110 patients with herpes pharyngitis in our hospital were selected. They were randomly divided into the two groups on average. The control group was given oral smecta treatment. On this basis, the observation group received intravenous injection of Xiyanping treatment. After 7 days of treatment, the therapeutic effect of the two groups was observed. Results:The clinical efficacy of the observation group was better than that of the control group (P0. 05) . No adverse reaction occurred. Conclusion:The use of intravenous injection of Xiyan Ping injection combined with oral Smecta (montmorilIonite powder) in the treatment of children with herpes zoster pharyngitis has significant effect and high safety. Keyword： Xi Yanping; Smecta (montmori1lonite powder) ; Herpes pharyngitis; 目前临床中治疗小儿疱疹性咽炎普遍采用的药物为喜炎平或思密达(蒙脱石 散)，然而将喜炎平与思密达结合将产生更显著的治疗效果m。现将喜炎平联 合思密达治疗小儿疱疹性咽炎的疗效和安全性进行如下报告。 资料与方法 2015年2月-2017年2月收治小儿疱疹性咽炎患者110例，将其分为对照组与观 察组。对照组55例，男38例，女17例；年龄广6岁，平均3. 5岁。观察组55 例，男42例，女13例;年龄2~7岁，平均年龄4. 5岁。将两组一般资料录入统 计学软件中处理，差异无统计学意义(P〉0.05)，具有可比性。 方法:对照组:予以U服思密达的治疗方式，具体的服用方法：(1) 1岁的儿童 每天服用1袋，分3次服用。(2)广2岁的儿童服用广2袋八1，并分3次服用。 2岁的儿童服用2~3袋/d,分3次服用。观察组:予以静脉注射喜炎平的治 疗方式，并口服思密达(蒙脱石散)。每次静脉注射喜炎平的用量5~10 mg, 1 次/d;思密达用法同对照组。两组治疗周期均为7 d。 表1两组临床疗效比较[n (%)] 下载原表 表2 表2两组临床症状改善情况比较[n (%)] 下载原表 观察指标：（1）观察两组临床疗效。（2）观察两组不良反应。（3）观察两组临 床